Clinical Trial Update: Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial compares paclitaxel plus carboplatin against standard chemotherapy for patients with unresectable stage III or stage IV non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Lung Cancer | Phase 3 | Status: UNKNOWN